{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:43:10Z","timestamp":1770932590538,"version":"3.50.1"},"reference-count":179,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Respiratory Medicine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1586\/17476348.2014.852960","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T04:24:56Z","timestamp":1387340696000},"page":"43-55","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations"],"prefix":"10.1586","volume":"8","author":[{"given":"Kerry-Ann F","family":"O\u2019Grady","sequence":"first","affiliation":[{"name":"The University of Queensland, Queensland Children\u2019s Medical Research Institute,","place":["Australia"]},{"name":"Queensland University of Technology, Queensland Children\u2019s Medical Research Institute,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne B","family":"Chang","sequence":"additional","affiliation":[{"name":"Queensland University of Technology, Queensland Children\u2019s Medical Research Institute,","place":["Australia"]},{"name":"Charles Darwin University, Menzies School of Health Research,","place":["Australia"]},{"name":"Department of Respiratory Medicine, Royal Children\u2019s Hospital,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Grimwood","sequence":"additional","affiliation":[{"name":"The University of Queensland, Queensland Children\u2019s Medical Research Institute,","place":["Australia"]},{"name":"Department of Infectious Diseases, Royal Children\u2019s Hospital,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1745-6215-14-282","article-title":"Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial","volume":"14","author":"O\u2019Grady KF","year":"2013","unstructured":"O\u2019Grady KF, Grimwood K, Cripps AW et al. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. Trials 14, 282 (2013).","journal-title":"Trials"},{"key":"e_1_3_3_6_1","first-page":"CD006340","article-title":"Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults","volume":"4","author":"Petsky HL","year":"2009","unstructured":"Petsky HL, Cates CJ, Li A et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst. Rev. (4), CD006340 (2009).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0490"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.05.007"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00077-12"},{"issue":"4","key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10096-009-0865-7","article-title":"Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction","volume":"29","author":"Meerhoff TJ","year":"2010","unstructured":"Meerhoff TJ, Houben ML, Coenjaerts FE et al. Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction. Eur. J. Clin. Microbiol. Infect. Dis. 29(4), 365\u2013371 (2010).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis"},{"issue":"5","key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/INF.0b013e3182833c90","article-title":"New aspects on human rhinovirus infections","volume":"32","author":"Ruuskanen O","year":"2013","unstructured":"Ruuskanen O, Waris M, Ramilo O. New aspects on human rhinovirus infections. Pediatr. Infect. Dis. J. 32(5), 553\u2013555 (2013).","journal-title":"Pediatr. Infect. Dis. J"},{"issue":"11","key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1128\/JCM.01685-09","article-title":"Breathing new life into pneumonia diagnostics","volume":"47","author":"Murdoch DR","year":"2009","unstructured":"Murdoch DR, O'Brien KL, Scott JA et al. Breathing new life into pneumonia diagnostics. J. Clin. Microbiol. 47(11), 3405\u20133408 (2009).","journal-title":"J. Clin. Microbiol"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201205-0806OC"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201006-0833OC"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Molyneaux PL Mallia P Cox MJ et al. Outgrowth of the bacterial airway microbiome following rhinovirus exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. doi:10.1164\/rccm.201302-0341OC (2013) (Epub ahead of print).","DOI":"10.1164\/rccm.201302-0341OC"},{"issue":"1","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cid\/cis297","article-title":"Viruses associated with pneumonia in adults","volume":"55","author":"Cesario TC","year":"2012","unstructured":"Cesario TC. Viruses associated with pneumonia in adults. Clin. Infect. Dis. 55(1), 107\u2013113 (2012).","journal-title":"Clin. Infect. Dis"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-6627-3_15"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(01)00491-5"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199411000-00009"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/423820"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70520-5"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1086\/374624"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.06.002"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21550"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.9.759"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","unstructured":"Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 117(5 Suppl. 2) 380S\u2013385S (2000).","DOI":"10.1378\/chest.117.5_suppl_2.380S"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.6.1557"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800353"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044113"},{"issue":"4","key":"e_1_3_3_30_1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1368-5031.2006.00858.x","article-title":"Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?","volume":"60","author":"Fletcher MA","year":"2006","unstructured":"Fletcher MA, Laufer DS, McIntosh ED et al. Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient? Int. J. Clin. Pract. 60(4), 450\u2013456 (2006).","journal-title":"Int. J. Clin. Pract"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00122-X"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.07.029"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.043323"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022678"},{"issue":"1","key":"e_1_3_3_35_1","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"Moberley SA","year":"2008","unstructured":"Moberley SA, Holden J, Tatham DP et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. (1), CD000422 (2008).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00112-3"},{"issue":"2","key":"e_1_3_3_37_1","first-page":"CD006316","article-title":"Pneumococcal vaccines for children and adults with bronchiectasis","author":"Chang CC","year":"2009","unstructured":"Chang CC, Singleton R, Morris P et al. Pneumococcal vaccines for children and adults with bronchiectasis. Cochrane Database Syst. Rev. (2), CD006316 (2009).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283218356"},{"issue":"9127","key":"e_1_3_3_39_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(05)79285-0","article-title":"Use of pneumococcal polysaccharide vaccine in children","volume":"352","author":"Obaro S","year":"1998","unstructured":"Obaro S, Leach A, McAdam KW. Use of pneumococcal polysaccharide vaccine in children. Lancet 352(9127), 575 (1998).","journal-title":"Lancet"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.2.367"},{"key":"e_1_3_3_41_1","unstructured":"National Health & Medical Research Council. The Australian Immunisation Handbook (10th Edition). Australian Government Canberra Australia (2013)."},{"issue":"4","key":"e_1_3_3_42_1","first-page":"281","article-title":"Pneumococcal polysaccharide vaccine prevents death from pneumonia in Papua New Guinean children","volume":"29","author":"Lehmann D","year":"1986","unstructured":"Lehmann D. Pneumococcal polysaccharide vaccine prevents death from pneumonia in Papua New Guinean children. PNG Med. J. 29(4), 281\u2013283 (1986).","journal-title":"PNG Med. J"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.Supplement_6.S535"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90409-5"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/inf.1980.12.issue-2.04"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283531b0f"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00018-12"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31824de9f6"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.68"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1086\/503805"},{"issue":"2","key":"e_1_3_3_51_1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/infdis\/jir730","article-title":"Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities","volume":"205","author":"Scott JR","year":"2012","unstructured":"Scott JR, Millar EV, Lipsitch M et al. Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J. Infect. Dis. 205(2), 280\u2013288 (2012).","journal-title":"J. Infect. Dis"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039730"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209165"},{"key":"e_1_3_3_54_1","first-page":"CD008865","article-title":"Pneumococcal vaccines for cystic fibrosis","volume":"9","author":"Burgess L","year":"2012","unstructured":"Burgess L, Southern KW. Pneumococcal vaccines for cystic fibrosis. Cochrane Database Syst. Rev. 9, CD008865 (2012).","journal-title":"Cochrane Database Syst. Rev"},{"issue":"11","key":"e_1_3_3_55_1","first-page":"CD001390","article-title":"Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease","author":"Walters JA","year":"2010","unstructured":"Walters JA, Smith S, Poole P et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. (11), CD001390 (2010).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis513"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02036-12"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1086\/515058"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2012-302968"},{"key":"e_1_3_3_60_1","doi-asserted-by":"crossref","unstructured":"Mooi FR NA VDM De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol. Infect. 1\u201310 (2013).","DOI":"10.1017\/S0950268813000071"},{"key":"e_1_3_3_61_1","doi-asserted-by":"crossref","unstructured":"Jackson DW Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol. Infect. 1\u201313 (2013).","DOI":"10.1017\/S0950268812003093"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.6364"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit046"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-1928"},{"issue":"8","key":"e_1_3_3_65_1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/rmed.2000.0823","article-title":"Interaction of Bordetella pertussis with human respiratory mucosa","volume":"94","author":"Soane MC","year":"2000","unstructured":"Soane MC, Jackson A, Maskell D et al. Interaction of Bordetella pertussis with human respiratory mucosa in vitro. Respir. Med. 94(8), 791\u2013799 (2000).","journal-title":"in vitro. Respir. Med"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1086\/315648"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.11.020"},{"issue":"7","key":"e_1_3_3_68_1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/thx.2005.056291","article-title":"Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma","volume":"61","author":"Harju TH","year":"2006","unstructured":"Harju TH, Leinonen M, Nokso-Koivisto J et al. Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax 61(7), 579\u2013584 (2006).","journal-title":"Thorax"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.06.003"},{"key":"e_1_3_3_70_1","first-page":"1691","article-title":"Orthomyxoviruses","volume":"2","author":"Wright PF","year":"2007","unstructured":"Wright PF, Neumann G, Kawoaka Y. Orthomyxoviruses. In: Field's Virology. Volume 2, (5th Edition). Knipe DM (Ed.). Lippincott, Williams and Wilkins, Philadelphia, PA, USA, 1691\u20131740 (2007).","journal-title":"Field's Virology."},{"issue":"1","key":"e_1_3_3_71_1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1473-3099(10)70263-2","article-title":"Influenza in young children: burden, immunisation, and policy","volume":"11","author":"Steinhoff MC","year":"2011","unstructured":"Steinhoff MC. Influenza in young children: burden, immunisation, and policy. Lancet Infect. Dis. 11(1), 2\u20133 (2011).","journal-title":"Lancet Infect. Dis"},{"key":"e_1_3_3_72_1","first-page":"CD004876","article-title":"Vaccines for preventing influenza in the elderly","volume":"3","author":"Rivetti D","year":"2006","unstructured":"Rivetti D, Jefferson T, Thomas R et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst. Rev. 3, CD004876 (2006).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2012.00408.x"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1586\/ers.10.26"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.010"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.7774\/cevr.2012.1.1.35"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2010.01722.x"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2012.10.006"},{"issue":"12","key":"e_1_3_3_79_1","first-page":"1204","article-title":"Exacerbations of chronic obstructive pulmonary disease","volume":"48","author":"Wedzicha JA","year":"2003","unstructured":"Wedzicha JA, Donaldson GC: Exacerbations of chronic obstructive pulmonary disease. Respir. Care 48(12), 1204\u20131213, discussion 1213\u20131205 (2003).","journal-title":"Respir. Care"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.2147\/copd.2007.2.1.41"},{"issue":"1","key":"e_1_3_3_81_1","first-page":"CD002733","article-title":"Influenza vaccine for patients with chronic obstructive pulmonary disease","author":"Poole PJ","year":"2006","unstructured":"Poole PJ, Chacko E, Wood-Baker RW et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. (1), CD002733 (2006).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_82_1","first-page":"CD000364","article-title":"Vaccines for preventing influenza in people with asthma","volume":"2","author":"Cates CJ","year":"2013","unstructured":"Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst. Rev. 2, CD000364 (2013).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31818a545d"},{"issue":"3","key":"e_1_3_3_84_1","first-page":"CD006218","article-title":"Influenza vaccine for children and adults with bronchiectasis","author":"Chang CC","year":"2007","unstructured":"Chang CC, Morris PS, Chang AB. Influenza vaccine for children and adults with bronchiectasis. Cochrane Database Syst. Rev. (3), CD006218 (2007).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.13.12"},{"issue":"4","key":"e_1_3_3_86_1","first-page":"CD001753","article-title":"Vaccines for preventing influenza in people with cystic fibrosis","author":"Dharmaraj P","year":"2009","unstructured":"Dharmaraj P, Smyth RL. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst. Rev. (4), CD001753 (2009).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_87_1","doi-asserted-by":"crossref","first-page":"f3037","DOI":"10.1136\/bmj.f3037","article-title":"Influenza: marketing vaccine by marketing disease","volume":"346","author":"Doshi P","year":"2013","unstructured":"Doshi P. Influenza: marketing vaccine by marketing disease. BMJ 346, f3037 (2013).","journal-title":"BMJ"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70295-X"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00058-05"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1086\/341462"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1077"},{"issue":"3","key":"e_1_3_3_92_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1574-695X.1999.tb01389.x","article-title":"Respiratory viral infection predisposing for bacterial disease: a concise review","volume":"26","author":"Hament JM","year":"1999","unstructured":"Hament JM, Kimpen JL, Fleer A et al. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol. Med. Microbiol. 26(3\u20134), 189\u2013195 (1999).","journal-title":"FEMS Immunol. Med. Microbiol"},{"issue":"1","key":"e_1_3_3_93_1","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/01.inf.0000108197.81270.35","article-title":"Respiratory viruses predisposing to bacterial infections: role of neuraminidase","volume":"23","author":"Peltola VT","year":"2004","unstructured":"Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect. Dis. J. 23(1 Suppl.), S87\u201397 (2004).","journal-title":"Pediatr Infect. Dis. J"},{"issue":"7","key":"e_1_3_3_94_1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/INF.0b013e3182539d92","article-title":"Viral load and acute otitis media development after human metapneumovirus upper respiratory tract infection","volume":"31","author":"Nokso-Koivisto J","year":"2012","unstructured":"Nokso-Koivisto J, Pyles RB, Miller AL et al. Viral load and acute otitis media development after human metapneumovirus upper respiratory tract infection. Pediatr Infect. Dis. J. 31(7), 763\u2013766 (2012).","journal-title":"Pediatr Infect. Dis. J"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.12.002"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit003"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00114-0"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0799"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.05.037"},{"key":"e_1_3_3_100_1","volume-title":"Vaccines","author":"Plotkin SA","year":"2004","unstructured":"Plotkin SA. A short history of vaccination. In: Vaccines (4th Edition). Plotkin SA, Orenstein WA, Offit PA (Eds). Saunders, Philadelphia, PA, USA (2004).","edition":"4"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00040-06"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05476-11"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32835310a4"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61203-4"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-006-0062-0"},{"issue":"3","key":"e_1_3_3_106_1","first-page":"77","article-title":"Greally P: A decade of non-cystic fibrosis bronchiectasis 1996-2006","volume":"103","author":"Zaid AA","year":"2010","unstructured":"Zaid AA, Elnazir B, Greally P: A decade of non-cystic fibrosis bronchiectasis 1996-2006. Ir. Med. J. 103(3), 77\u201379 (2010).","journal-title":"Ir. Med. J"},{"issue":"1","key":"e_1_3_3_107_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1817-1737.30354","article-title":"A review of 151 cases of pediatric noncystic fibrosis bronchiectasis in a tertiary care center","volume":"2","author":"Banjar HH","year":"2007","unstructured":"Banjar HH. A review of 151 cases of pediatric noncystic fibrosis bronchiectasis in a tertiary care center. Ann. Thorac. Med. 2(1), 3\u20138 (2007).","journal-title":"Ann. Thorac. Med"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1159\/000085362"},{"issue":"2","key":"e_1_3_3_109_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ppul.21331","article-title":"Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?","volume":"46","author":"Munro KA","year":"2010","unstructured":"Munro KA, Reed PW, Joyce H et al. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression? Pediatr. Pulmonol. 46(2), 131\u2013138 2010.","journal-title":"Pediatr. Pulmonol"},{"issue":"2","key":"e_1_3_3_110_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.prrv.2010.10.009","article-title":"Airway microbiology and host defences in paediatric non-CF bronchiectasis","volume":"12","author":"Grimwood K","year":"2011","unstructured":"Grimwood K. Airway microbiology and host defences in paediatric non-CF bronchiectasis. Paediatr. Respir. Rev. 12(2), 111\u2013118 (2011).","journal-title":"Paediatr. Respir. Rev"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.954"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21526"},{"issue":"11","key":"e_1_3_3_113_1","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1164\/ajrccm.164.11.2104093","article-title":"Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis","volume":"164","author":"Bandi V","year":"2001","unstructured":"Bandi V, Apicella MA, Mason E. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am. J. Respir. Crit. Care Med. 164(11), 2114\u20132119 (2001).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00507-6"},{"issue":"8469","key":"e_1_3_3_115_1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(85)92559-0","article-title":"Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease","author":"Clancy R","year":"1985","unstructured":"Clancy R, Cripps A, Murree-Allen K et al. Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet 2(8469\u20138470), 1395\u20131397 (1985).","journal-title":"Lancet"},{"issue":"4","key":"e_1_3_3_116_1","first-page":"CD001958","article-title":"Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis","author":"Foxwell AR","year":"2006","unstructured":"Foxwell AR, Cripps AW, Dear KB. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis. Cochrane Database Syst. Rev. (4), CD001958 (2006).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.2.324"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1382"},{"key":"e_1_3_3_119_1","unstructured":"Wallace FJ Cripps AW Clancy RL et al. A role for intestinal T lymphocytes in bronchus mucosal immunity Immunology 74(1) 68\u201373 (1991)."},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1086\/527396"},{"issue":"35","key":"e_1_3_3_121_1","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1016\/j.vaccine.2008.05.080","article-title":"Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines","volume":"26","author":"Prymula R","year":"2008","unstructured":"Prymula R, Chlibek R, Splino M et al. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. Vaccine 26(35), 4563\u20134570 (2008).","journal-title":"Vaccine"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.113"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68304-9"},{"key":"e_1_3_3_124_1","doi-asserted-by":"crossref","unstructured":"S\u00e1ez-Llorens X D. Wong M. Rodr\u00edguez. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) nasopharyngeal bacterial carriage in Panamanian children. Presented at: 29th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). The Hague The Netherlands 16\u201319 November 2011.","DOI":"10.1016\/j.vaccine.2010.12.086"},{"key":"e_1_3_3_125_1","unstructured":"S\u00e1ez-Llorens X. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) against acute otitis media in children in Panama. Presented at: 9th International Symposium on Antimicrobial Agents and Resistance (ISAAR). Kuala Lumpur Malaysia 13\u201315 March 2013."},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis922"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.033"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2012.03.001"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200708-1234OC"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1086\/599375"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.8.1.77"},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064422"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.062"},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00314-10"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70285-1"},{"key":"e_1_3_3_136_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200802-327OC"},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2010.08.002"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2009.07.010"},{"issue":"1","key":"e_1_3_3_139_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1843.2006.00999.x","article-title":"Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa","volume":"12","author":"Lin SH","year":"2007","unstructured":"Lin SH, Kuo PH, Hsueh PR et al. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology 12(1), 81\u201387 (2007).","journal-title":"Respirology"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.03.009"},{"key":"e_1_3_3_141_1","first-page":"1347","volume-title":"Vaccines","author":"Gregerson A","year":"2004","unstructured":"Gregerson A, Daum RS. Staphylococcus aureus vaccine. In: Vaccines (4th Edition). Plotkin SA, Orenstein W (Eds). Elsevier Inc., Philadelphia, PA, 1347\u20131355 (2004).","edition":"4"},{"key":"e_1_3_3_142_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis033"},{"key":"e_1_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.25182"},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.006"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70295-4"},{"key":"e_1_3_3_146_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.18946"},{"issue":"1","key":"e_1_3_3_147_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.diagmicrobio.2010.04.008","article-title":"Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease","volume":"68","author":"Valderrey AD","year":"2010","unstructured":"Valderrey AD, Pozuelo MJ, Jimenez PA et al. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. Diagn. Microbiol. Infect. Dis. 68(1), 20\u201327 (2010).","journal-title":"Diagn. Microbiol. Infect. Dis"},{"key":"e_1_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.12.88"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00036-10"},{"key":"e_1_3_3_150_1","first-page":"CD001399","article-title":"Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis","volume":"6","author":"Johansen HK","year":"2013","unstructured":"Johansen HK, Gotzsche PC. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis. Cochrane Database Syst. Rev. 6, CD001399 (2013).","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_3_151_1","volume-title":"Clinical Trial Protocol No. KV9909. Double-Blind, Randomised, Placebo Controlled, Multi-Centre trial to Determine the Efficacy of Aerugen Berna Vaccine to Prevent Respiratory Tract Infections with P. aeruginosa in Non-Colonised Patients with Cystic Fibrosis","author":"Lang A","year":"2000","unstructured":"Lang A. Clinical Trial Protocol No. KV9909. Double-Blind, Randomised, Placebo Controlled, Multi-Centre trial to Determine the Efficacy of Aerugen Berna Vaccine to Prevent Respiratory Tract Infections with P. aeruginosa in Non-Colonised Patients with Cystic Fibrosis. Swiss Serum and Vaccine Institute, Bern, Switzerland (2000)."},{"issue":"26","key":"e_1_3_3_152_1","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.1073\/pnas.0702403104","article-title":"A double-blind randomized placebo-controlled Phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients","volume":"104","author":"Doring G","year":"2007","unstructured":"Doring G, Meisner C, Stern M et al. A double-blind randomized placebo-controlled Phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proc. Natl Acad. Sci. USA 104(26), 11020\u201311025 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"12","key":"e_1_3_3_153_1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/adc.59.12.1131","article-title":"Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results","volume":"59","author":"Langford DT","year":"1984","unstructured":"Langford DT, Hiller J. Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results. Arch. Dis. Child 59(12), 1131\u20131134 (1984).","journal-title":"Arch. Dis. Child"},{"key":"e_1_3_3_154_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201202-0182OC"},{"key":"e_1_3_3_155_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.1"},{"key":"e_1_3_3_156_1","first-page":"1601","volume-title":"Field's Virology. Volume 2 (5th Edition)","author":"Collins PL","year":"2007","unstructured":"Collins PL, Crowe JE. Respiratory syncytial virus and metapneumovirus. In: Field's Virology. Volume 2 (5th Edition). Knipe DM (Ed.). Lippincott, Williams and Wilkins, Philadelphia, PA, 1601\u20131646 (2007)."},{"key":"e_1_3_3_157_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152612800100099"},{"key":"e_1_3_3_158_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2012.00345.x"},{"key":"e_1_3_3_159_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis309"},{"key":"e_1_3_3_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60206-1"},{"key":"e_1_3_3_161_1","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2012.744741"},{"key":"e_1_3_3_162_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e328360bd2e"},{"key":"e_1_3_3_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2013.04.011"},{"key":"e_1_3_3_164_1","volume-title":"Vaccines","author":"Karron RA","year":"2004","unstructured":"Karron RA. Respiratory Syncytial Virus Vaccine. In: Vaccines (4th Edition) Plotkin SA, Orenstein W (Eds). Elsevier, Philadelphia, PA (2004).","edition":"4"},{"key":"e_1_3_3_165_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.120"},{"key":"e_1_3_3_166_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.053686-0"},{"key":"e_1_3_3_167_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6989.1225"},{"key":"e_1_3_3_168_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6910.982"},{"issue":"2","key":"e_1_3_3_169_1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1183\/09031936.00149009","article-title":"Childhood asthma and infection: virus-induced exacerbations as determinants and modifiers","volume":"36","author":"Xepapadaki P","year":"2010","unstructured":"Xepapadaki P, Papadopoulos NG. Childhood asthma and infection: virus-induced exacerbations as determinants and modifiers. Eur. Respir. J. 36(2), 438\u2013445 (2010).","journal-title":"Eur. Respir. J"},{"key":"e_1_3_3_170_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.9.2105011"},{"issue":"1","key":"e_1_3_3_171_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09031936.00145710","article-title":"Rhinovirus vaccination: the case against","volume":"37","author":"Papi A","year":"2011","unstructured":"Papi A, Contoli M. Rhinovirus vaccination: the case against. Eur. Respir. J. 37(1), 5\u20137 (2011).","journal-title":"Eur. Respir. J"},{"key":"e_1_3_3_172_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00136510"},{"key":"e_1_3_3_173_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00149109"},{"key":"e_1_3_3_174_1","doi-asserted-by":"publisher","DOI":"10.1038\/317145a0"},{"key":"e_1_3_3_175_1","volume-title":"Vaccination Uptake Among People with Chronic Lung Disease. Cat # ACM25","author":"Australian Institute of Health & Welfare","year":"2012","unstructured":"Australian Institute of Health & Welfare. Vaccination Uptake Among People with Chronic Lung Disease. Cat # ACM25. Australian Government, Canberra, Australia (2012)."},{"key":"e_1_3_3_176_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckr094"},{"key":"e_1_3_3_177_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.09.010"},{"key":"e_1_3_3_178_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.20204"},{"key":"e_1_3_3_179_1","doi-asserted-by":"publisher","DOI":"10.1586\/ers.13.24"},{"key":"e_1_3_3_180_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.811188"},{"key":"e_1_3_3_181_1","doi-asserted-by":"crossref","first-page":"D14","DOI":"10.1016\/j.vaccine.2010.08.025","article-title":"Seasonal influenza vaccinations: specialized products for different target groups","volume":"28","author":"Monto AS","year":"2010","unstructured":"Monto AS. Seasonal influenza vaccinations: specialized products for different target groups. Vaccine 28(Suppl. 28), D14\u201323 (2010).","journal-title":"Vaccine"},{"key":"e_1_3_3_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.03.022"},{"key":"e_1_3_4_2_1","unstructured":"GlaxoSmithKline Biologicals. COMPAS: a Phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media. Protocol ID 109563_1. www.gsk-clinicalstudyregister.com"}],"container-title":["Expert Review of Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/17476348.2014.852960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:01:08Z","timestamp":1770930068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/17476348.2014.852960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,2]]},"references-count":179,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.1586\/17476348.2014.852960"],"URL":"https:\/\/doi.org\/10.1586\/17476348.2014.852960","relation":{},"ISSN":["1747-6348","1747-6356"],"issn-type":[{"value":"1747-6348","type":"print"},{"value":"1747-6356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2013-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}